Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Cymabay Therapeu (CBAY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Cymabay Therapeu's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Cymabay Therapeu historical data, for real-time data please try another search
32.480 +0.000    +0.00%
21/03 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 32.480 - 32.500
Cymabay Therapeu 32.480 +0.000 +0.00%

Cymabay Therapeu Company Profile

 
Get an in-depth profile of Cymabay Therapeu, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

101

Equity Type

ORD

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta for the treatments of primary biliary cholangitis (PBC). The company also develops MBX-2982, a G protein-coupled receptor 119 (GPR119) agonist, in subjects with type 1 diabetes. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Fremont, California. As of March 22, 2024, CymaBay Therapeutics, Inc. operates as a subsidiary of Gilead Sciences, Inc.

Contact Information

Address 7601 Dumbarton Circle
Fremont, 94555
United States
Phone 510 293 8800
Fax -
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CBAY Comments

Write your thoughts about Cymabay Therapeu
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kakao Brown
Kakao Brown Sep 26, 2023 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Direct to the moon
Asim Hussain
Asim Hussain Aug 08, 2020 12:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Oppenheimer is manipulating this stock.
Richard broom
Richard broom Aug 08, 2020 12:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why?
fx Trade
itr4de Aug 06, 2020 5:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrows direction?
omar omar
omar omar Aug 05, 2020 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stagnant
Eric Tenbarge
Eric Tenbarge Aug 05, 2020 2:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what gives?
willie porche
willie porche Jul 23, 2020 9:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Test trials approved...going sky high today!
willie porche
willie porche Jun 22, 2020 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's moving today!
Kathy Knowlton
Kathy Knowlton Jun 11, 2020 7:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
not good forecast outlook for this stock.
willie porche
willie porche Jun 11, 2020 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
getting ready to cut my losses on this one...
Robert Dean
Robert Dean Jun 11, 2020 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
well for the month hoddle it's on the up
Imanol Lopez
Imanol Lopez May 18, 2020 3:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why has a strong buy? Dont get it
Imanol Lopez
Imanol Lopez May 12, 2020 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is tomorrow going up?
The SFactor
The SFactor May 12, 2020 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
that's an understatement, it's going nuclear tomorrow!
Gyorgy Cseke
Gyorgy Cseke May 12, 2020 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sure
Gyorgy Cseke
Gyorgy Cseke May 12, 2020 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
going down
Imanol Lopez
Imanol Lopez May 12, 2020 1:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hopepully today is upper 💪🏻
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email